Could Rapamycin Help Humans Live Longer? From Extending Lifespan to Bolstering the Immune System, the Drug’s Effects are Only Just Beginning to be Understood

Time: 9:30 am - 9:50 am

Date: 28 April 2020


An in depth review of the discovery of this molecule, its immunosuppresent and anticancer activity. It’s particular novel use in the topical treatment of tuberous sclerosis compex ( TSC)
We will look at Rapamycin’s effects and the potential for the molecule to be mediated by the microbiome, which has multiple effects on immune system function.
We also look at how studies of the health benefit for humans are gaining traction.


  • Michael Schaeffler Pharmaceutical Project Manager for Ubichem's Supplier Partner CFM Oscar Tropitzsch GMBH - Ubichem

« Back